Fate Therapeutics (FATE) EPS (Basic) (2012 - 2026)
Fate Therapeutics (FATE) posted EPS (Basic) of -$1.23 for Q1 2026, down 349.8% on a QoQ basis from -$0.27 in Q4 2025, and up 13.22% year-over-year from -$1.09 in Q1 2025.
Fate Therapeutics (FATE) EPS (Basic) (2012 - 2026) Analysis & Trends
Fate Therapeutics' EPS (Basic) history runs 15 years deep, the most recent figure standing at -$1.23 for Q1 2026.
- Quarterly EPS (Basic) rose 13.22% year-over-year to -$1.23 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.5 (up 69.87% YoY) and the FY2025 annual result came in at -$4.42, up 9.54% from the prior year.
- EPS (Basic) was -$1.23 for Q1 2026 at Fate Therapeutics, down from -$0.27 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.27 in Q4 2025 and bottomed at -$3.74 in Q4 2023.
- A 5-year average of -$1.71 and a median of -$1.42 in 2025 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) sank 105.16% — and 2025, when it jumped 92.59%.
- Fate Therapeutics' EPS (Basic) stood at -$3.7 in 2022, then fell by 1.09% to -$3.74 in 2023, then rose by 1.11% to -$3.69 in 2024, then soared by 92.59% to -$0.27 in 2025, then tumbled by 349.8% to -$1.23 in 2026.
- Business Quant data shows FATE's EPS (Basic) at -$1.23 in Q1 2026, -$0.27 in Q4 2025, and -$0.63 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Fate Therapeutics | 288.82 Mn | 288.82 Mn | - | -1.23 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.23 |
| Dec 31, 2025 | -0.27 |
| Sep 30, 2025 | -0.63 |
| Jun 30, 2025 | -0.38 |
| Mar 31, 2025 | -1.42 |
| Dec 31, 2024 | -3.69 |
| Sep 30, 2024 | -1.70 |
| Jun 30, 2024 | -1.67 |
| Mar 31, 2024 | -1.03 |
| Dec 31, 2023 | -3.74 |
| Sep 30, 2023 | -2.16 |
| Jun 30, 2023 | -1.24 |
| Mar 31, 2023 | -0.93 |
| Dec 31, 2022 | -3.70 |
| Sep 30, 2022 | -1.60 |
| Jun 30, 2022 | -2.77 |
| Mar 31, 2022 | -0.93 |
| Dec 31, 2021 | -3.12 |
| Sep 30, 2021 | -2.54 |
| Jun 30, 2021 | -1.35 |